Take Action: Tell the FDA Your Thoughts on Sotagliflozin
New T1D Equity Framework Partnership with Medtronic Inc.
CDC Adds T1D as Medical Condition Associated with Higher Risk for Severe COVID-19
The Centers for Disease Control (CDC) has added type 1 diabetes (T1D) as one of the medical conditions associated with…
DiabetesMine: Adjusting Basal (Background) Insulin for Max Impact
“You only need a few days of living with type 1 diabetes (T1D) under your belt to realize just how…
Panel Discussion on Health Inequities in Type 1 Diabetes
We Honor These Words
“Life’s most urgent and persistent question is, What are you doing for others?” – Martin Luther King Jr T1D Exchange…
Tidepool Completes FDA 510(k) Submission of Tidepool Loop
Open Source Diabetes Nonprofit Submits Automated Insulin Dosing App for iPhone for FDA Review Tidepool, a 501(c)3 nonprofit, today announced…
Racial Inequities Among People with Type 1 Diabetes and COVID-19
T1D Exchange is honored to have our recent study results examining racial inequities among people with type 1 diabetes and COVID-19 included in two major publications. Structural and systemic…
JOIN US: The Impact of Virtual Care in T1D
JOIN OUR WEBINAR: “The Impact of Virtual Care in T1D” Learn how telemedicine and remote monitoring are impacting care provided…
2020 Highlights from the T1D Exchange Quality Improvement Collaborative
While the world was put on hold due to COVID-19, we did not press pause on type 1 diabetes research….
